Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Traws Pharma (TRAW) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Traws Pharma (TRAW) over the last 14 years, with Q3 2025 value amounting to $96000.0.

  • Traws Pharma's Non Operating Income rose 5737.7% to $96000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $258000.0, marking a year-over-year decrease of 6662.35%. This contributed to the annual value of $289000.0 for FY2024, which is 7859.26% down from last year.
  • Traws Pharma's Non Operating Income amounted to $96000.0 in Q3 2025, which was up 5737.7% from $188000.0 recorded in Q2 2025.
  • Traws Pharma's Non Operating Income's 5-year high stood at $362000.0 during Q1 2023, with a 5-year trough of -$206000.0 in Q4 2024.
  • Its 5-year average for Non Operating Income is $146210.5, with a median of $180000.0 in 2025.
  • As far as peak fluctuations go, Traws Pharma's Non Operating Income skyrocketed by 3150000.0% in 2022, and later crashed by 17410.07% in 2024.
  • Quarter analysis of 5 years shows Traws Pharma's Non Operating Income stood at -$1000.0 in 2021, then soared by 31500.0% to $314000.0 in 2022, then decreased by 11.46% to $278000.0 in 2023, then tumbled by 174.1% to -$206000.0 in 2024, then soared by 146.6% to $96000.0 in 2025.
  • Its last three reported values are $96000.0 in Q3 2025, $188000.0 for Q2 2025, and $180000.0 during Q1 2025.